Deals -

ERM has acted for Maverick Ventures (Israel) II LP in a $13,000,000 million Series B investment round in Orasis Pharmaceuticals.

ERM has acted for the second fund of Maverick Ventures (Israel) II LP in a Series B investment round in Orasis Pharmaceuticals. Maverick Ventures co invested along with Sequoia Capital, Visionary Venture Fund, SBI JI Innovation, LIFESCI 100 Plus Management Partnerships. Orasis pharmaceuticals raised in total approximately $13,000,000 million.

The ERM team was led by Adv. Natalie Noy, partner head of our Hi-Tech practice and Adv. Raz Mechalovich.

For media coverage of the investment, please click here.

Download as PDF
Share:

Media